US87918A1051
US87918A1051
Teladoc Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.05B EUR | 1.54B EUR | 983.35M EUR | 1.25B EUR |
Enterprise Value | 1.27B EUR | 1.8B EUR | 1.27B EUR | 1.51B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -7.98x | -- | -- | -- |
Price to Sales | 0.42x | 0.62x | 0.39x | 0.66x |
Price to Book | 0.8x | 1.18x | 0.74x | 0.9x |
EV/Revenue | 0.51x | 0.72x | 0.51x | 0.79x |
EV/EBITDA | 19.65x | 7.03x | 4.86x | 7.18x |
Price to FCF (P/FCF) | 5.49x | 13.04x | 7.76x | 8.16x |
EV/FCF | 6.64x | 15.26x | 10.03x | 9.85x |
FCF Yield | 18.22% | 7.67% | 12.88% | 12.26% |